Health-Chem Corporation
Health-Chem Corporation, through its subsidiary, Transderm Laboratories Corporation, engages in the research, development, manufacture, and marketing of transdermal drug delivery systems in the United States. It offers transdermal nitroglycerin patches used for transdermal relief of the vascular and cardiovascular symptoms related to angina pectoris (chest pain). The company also conducts researc… Read more
Health-Chem Corporation (HCLC) - Total Liabilities
Latest total liabilities as of June 2007: $21.97 Million USD
Based on the latest financial reports, Health-Chem Corporation (HCLC) has total liabilities worth $21.97 Million USD as of June 2007.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Health-Chem Corporation - Total Liabilities Trend (1985–2006)
This chart illustrates how Health-Chem Corporation's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Health-Chem Corporation Competitors by Total Liabilities
The table below lists competitors of Health-Chem Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Everlert Inc
PINK:EVLI
|
USA | $1.39 Million |
|
OncoVista Innovative Therapies Inc
PINK:OVIT
|
USA | $6.65 Million |
|
GeckoSystems International Corp
PINK:GOSY
|
USA | $318.33K |
|
Resgreen Group International Inc
PINK:RGGI
|
USA | $7.09 Million |
|
Technology Solutions Co
PINK:TSCC
|
USA | $1.27 Million |
|
Diamond Discov Intl
PINK:DMDD
|
USA | $2.09 Million |
|
Black Dragon Resource Companies Inc
PINK:BDGR
|
USA | $3.00 Million |
|
SPO Networks Inc
PINK:SPOI
|
USA | $9.08 Million |
Liability Composition Analysis (1985–2006)
This chart breaks down Health-Chem Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.20 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.34 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 3.97 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Health-Chem Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Health-Chem Corporation (1985–2006)
The table below shows the annual total liabilities of Health-Chem Corporation from 1985 to 2006.
| Year | Total Liabilities | Change |
|---|---|---|
| 2006-12-31 | $22.38 Million | +2.20% |
| 2005-12-31 | $21.90 Million | +10.79% |
| 2004-12-31 | $19.77 Million | +13.91% |
| 2003-12-31 | $17.35 Million | -33.27% |
| 1997-12-31 | $26.00 Million | +2.77% |
| 1996-12-31 | $25.30 Million | +0.40% |
| 1995-12-31 | $25.20 Million | +7.23% |
| 1994-12-31 | $23.50 Million | +2.17% |
| 1993-12-31 | $23.00 Million | -4.56% |
| 1992-12-31 | $24.10 Million | -34.86% |
| 1991-12-31 | $37.00 Million | -11.90% |
| 1990-12-31 | $42.00 Million | -15.32% |
| 1989-12-31 | $49.60 Million | +6.21% |
| 1988-12-31 | $46.70 Million | -11.22% |
| 1987-12-31 | $52.60 Million | +25.54% |
| 1986-12-31 | $41.90 Million | +1.95% |
| 1985-12-31 | $41.10 Million | -- |